What does PHARMA LAENEN do?

PHARMA LAENEN is a pharmacy in Geel. Private Limited, started on 7 March 2019, 1 establishment.

What is the address of PHARMA LAENEN?

The registered office of PHARMA LAENEN is located at Rozendaal 92, 2440 Geel.

Is PHARMA LAENEN still active?

Yes. According to the CBE (30 October 2026) PHARMA LAENEN is active, legal situation “Normale toestand”, started on 7 March 2019.

Is PHARMA LAENEN registered on Peppol?

Yes, PHARMA LAENEN is registered on the Peppol network with ID 0208:0721972681.

What is the enterprise number of PHARMA LAENEN?

The enterprise number of PHARMA LAENEN is BE0721972681.

When was PHARMA LAENEN founded?

PHARMA LAENEN was founded on 7 March 2019.

Who are the directors of PHARMA LAENEN?

According to the 2025 annual accounts, the directors of PHARMA LAENEN are: Leonie Laenen.

Is PHARMA LAENEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 March 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMA LAENEN make in 2025?

PHARMA LAENEN recorded a loss after taxes of € 9,012 in financial year 2025.

What is the revenue of PHARMA LAENEN?

As a small company, PHARMA LAENEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -2,891.

PHARMA LAENEN (Private Limited) - Geel - BE0721972681

Dossier PHARMA LAENEN, printed on 30 October 2026 from databakkes.be/en/0721972681/pharma-laenen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMA LAENEN from Geel, company number BE0721972681, closed financial year 2025 with a result of € -9,012 after tax. For that financial year PHARMA LAENEN recorded a gross margin of € -2,891 and equity of € 48,469. Compared with financial year 2024, the result moved from € 5,268 to € -9,012. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.

What it is worth Healthy

€ 48,469

▼ 33% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -9,012

▼ still € 5,268 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 44,240

▼ 44% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 29,869.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 11,589

▲ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,050

▼ 66% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,490

▼ 61% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 24,036 Gross margin 2022: € 24,036 First fiscal year in the series	€ 16,144 Gross margin 2023: € 16,144 ▼ 33% vs 2022 (€ 24,036) Unfavourable step	€ 12,387 Gross margin 2024: € 12,387 ▼ 23% vs 2023 (€ 16,144) Unfavourable step	€ -2,891 Gross margin 2025: € -2,891 ▼ € 15,279 vs 2024 (€ 12,387) Unfavourable step	▼ € 15,279
Profit after taxes	€ 12,915 Profit after taxes 2022: € 12,915 First fiscal year in the series	€ 3,341 Profit after taxes 2023: € 3,341 ▼ 74% vs 2022 (€ 12,915) Unfavourable step	€ 5,268 Profit after taxes 2024: € 5,268 ▲ 58% vs 2023 (€ 3,341) Favourable step	€ -9,012 Profit after taxes 2025: € -9,012 ▼ € 14,279 vs 2024 (€ 5,268) Unfavourable step	▼ € 14,279
Equity	€ 102,672 Equity 2022: € 102,672 First fiscal year in the series	€ 67,213 Equity 2023: € 67,213 ▼ 35% vs 2022 (€ 102,672) Unfavourable step	€ 72,481 Equity 2024: € 72,481 ▲ 8% vs 2023 (€ 67,213) Favourable step	€ 48,469 Equity 2025: € 48,469 ▼ 33% vs 2024 (€ 72,481) Unfavourable step	▼ 33%
Total debts	€ 15,149 Total debts 2022: € 15,149 First fiscal year in the series	€ 23,884 Total debts 2023: € 23,884 ▲ 58% vs 2022 (€ 15,149) Unfavourable step	€ 19,267 Total debts 2024: € 19,267 ▼ 19% vs 2023 (€ 23,884) Favourable step	€ 16,291 Total debts 2025: € 16,291 ▼ 15% vs 2024 (€ 19,267) Favourable step	▼ 15%
Cash	€ 63,229 Cash 2022: € 63,229 First fiscal year in the series	€ 64,658 Cash 2023: € 64,658 ▲ 2% vs 2022 (€ 63,229) Favourable step	€ 79,331 Cash 2024: € 79,331 ▲ 23% vs 2023 (€ 64,658) Favourable step	€ 44,240 Cash 2025: € 44,240 ▼ 44% vs 2024 (€ 79,331) Unfavourable step	▼ 44%
Retained profit	€ 90,272 Retained profit 2022: € 90,272 First fiscal year in the series	€ 48,613 Retained profit 2023: € 48,613 ▼ 46% vs 2022 (€ 90,272) Unfavourable step	€ 53,881 Retained profit 2024: € 53,881 ▲ 11% vs 2023 (€ 48,613) Favourable step	€ 29,869 Retained profit 2025: € 29,869 ▼ 45% vs 2024 (€ 53,881) Unfavourable step	▼ 45%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 45,000 Dividend 2023: € 45,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 45,000) Unchanged	€ 15,000 Dividend 2025: € 15,000 Unchanged (€ 0) Unchanged
Bank debt	€ 8,885 Bank debt 2022: € 8,885 First fiscal year in the series	€ 1,788 Bank debt 2023: € 1,788 ▼ 80% vs 2022 (€ 8,885) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 1,788) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 117,821 Balance sheet total 2022: € 117,821 First fiscal year in the series	€ 91,097 Balance sheet total 2023: € 91,097 ▼ 23% vs 2022 (€ 117,821) Unchanged	€ 91,748 Balance sheet total 2024: € 91,748 ▲ 1% vs 2023 (€ 91,097) Unchanged	€ 64,760 Balance sheet total 2025: € 64,760 ▼ 29% vs 2024 (€ 91,748) Unchanged	▼ 29%

Key figures of PHARMA LAENEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMA LAENEN?

What happened at PHARMA LAENEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 17, 2026 New annual accounts for financial year 2025: loss of € 9,012 (▼ € 14,279 vs 2024). Source: NBB ↗
Mar 7, 2019 New establishment in Geel. KBO
Mar 7, 2019 Start of the company according to the CBE. KBO

In short

From € 12,915 profit in 2022 to € 9,012 loss in 2025.

Paid € 10,038 in corporate taxes since 2022.

Best year ever: 2022, with € 12,915 profit.

Paid out € 60,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Leonie Laenen

PHARMA LAENEN

Behind PHARMA LAENEN is Leonie Laenen.

Directors

According to the 2025 annual accounts

Leonie Laenen

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rozendaal 92

2440 Geel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ROSHOEVE

€ 37,880 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0721.972.681
VAT number: BE 0721.972.681
Registered office: Rozendaal 92, 2440 Geel
Names & denominations: PHARMA LAENEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 March 2019
Peppol: Active · Active since 20 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗